- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03864887
Optical Assessment on Brain Death Via a Oxygen Supply Procedure
March 5, 2019 updated by: Ting Li, Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Optical Assessment on Brain Death Via a Multiple-phase Protocol at Varied Fraction of Inspired O2
This study aims to evaluate brain death with optical probes.
The changes of hemodynamic parameters including oxyhemoglobin (HbO2) and deoxyhemoglobin (Hb) were detected by near infrared spectroscopy probes attached on the forehead of patients.
A multiple-phase protocol at varied fraction of inspired O2 were utilized during the assessment.
Study Overview
Status
Unknown
Conditions
Detailed Description
Brain death is an irreversible loss of all brain functions, and the assessment is crucial for organ supply for transplantation.
The noninvasive, sensitive, universally available and timely ancillary method to assess brain death has not been established.
This study aims to evaluate brain death with optical probes.
The changes of hemodynamic parameters including oxyhemoglobin (HbO2) and deoxyhemoglobin (Hb) were detected by near infrared spectroscopy probes attached on the forehead of patients.
A multiple-phase protocol at varied fraction of inspired O2 were utilized during the assessment.
The concentration changes ratios of oxyhemoglobin to deoxyhemoglobin (Δ[HbO2]/Δ[Hb]) in the cerebral cortex of brain-dead patients were significantly higher than those of healthy subjects.
Study Type
Observational
Enrollment (Anticipated)
80
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Tianjin
-
Tianjin, Tianjin, China, 300000
- Recruiting
- NIRS assessment for brain death
-
Contact:
- Chenyang Gao, Doctor
- Phone Number: +86 16622803399
- Email: 505358234@qq.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 80 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Adult individuals of any gender.
Mostly hired in the City of Tianjin, P.R.China
Description
Inclusion Criteria:
- Patients who have had brain death or serious brain trauma.
- Healthy people who are interested in optical assessment of hemodynamic parameters
Exclusion Criteria:
- Patients who are in pregnancy or have plan to conception.
- Patients who have vertebra surgery or have plan of surgery.
Patients who are inappropriate to join this trial judged by the radiologists or specialists.
- AIDS, Active Hepatitis, Tuberculosis, Syphilis
- Patients who regularly take anticoagulants, antiplatelet drugs
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Healthy people for HLH Oxygen
Healthy people were supplied with oxygen at varied FIO2 at medical premised range.The protocol is Oxygen supply of high-low-high procedure.
During the procedures, the Δ[Hb] and Δ[HbO2] time courses were collected by Optical monitor for hemodynamic parameter.
|
The protocol consisted of 1-hour resting, 3-minute baseline measurement, half-hour measurement at 60% FIO2 (phase I, high oxygen), half-hour measurement at 40% FIO2 (phase II, low oxygen) and half-hour measurement at 60% FIO2 (phase III, high oxygen).
Near infrared spectroscopy probes of tow wavelengths were attached on the subjects' foreheat to detect the changes of hemodynamic parameters.
|
|
Healthy people for LHL Oxygen
Healthy people were supplied with oxygen at varied FIO2 at medical premised range.The protocol is Oxygen supply of low-high-low procedure.
During the procedures, the Δ[Hb] and Δ[HbO2] time courses were collected by Optical monitor for hemodynamic parameter.
|
Near infrared spectroscopy probes of tow wavelengths were attached on the subjects' foreheat to detect the changes of hemodynamic parameters.
The protocol consisted of 1-hour resting, 3-minute baseline measurement, half-hour measurement at 40% FIO2 (phase I, low oxygen), half-hour measurement at 60% FIO2 (phase II, high oxygen) and half-hour measurement at 40% FIO2 (phase III, low oxygen).
|
|
Brain death patients for HLH Oxygen
Brain-dead patients were supplied with oxygen at varied FIO2 at medical premised range.The protocol is Oxygen supply of high-low-high procedure.
During the procedures, the Δ[Hb] and Δ[HbO2] time courses were collected by Optical monitor for hemodynamic parameter.
|
The protocol consisted of 1-hour resting, 3-minute baseline measurement, half-hour measurement at 60% FIO2 (phase I, high oxygen), half-hour measurement at 40% FIO2 (phase II, low oxygen) and half-hour measurement at 60% FIO2 (phase III, high oxygen).
Near infrared spectroscopy probes of tow wavelengths were attached on the subjects' foreheat to detect the changes of hemodynamic parameters.
|
|
Brain death patients for LHL Oxygen
Brain-dead patients were supplied with oxygen at varied FIO2 at medical premised range.The protocol is Oxygen supply of low-high-low procedure.
During the procedures, the Δ[Hb] and Δ[HbO2] time courses were collected by Optical monitor for hemodynamic parameter.
|
Near infrared spectroscopy probes of tow wavelengths were attached on the subjects' foreheat to detect the changes of hemodynamic parameters.
The protocol consisted of 1-hour resting, 3-minute baseline measurement, half-hour measurement at 40% FIO2 (phase I, low oxygen), half-hour measurement at 60% FIO2 (phase II, high oxygen) and half-hour measurement at 40% FIO2 (phase III, low oxygen).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Δ[HbO2]
Time Frame: 1 day during the whole experiment
|
The changes of oxyhemoglobin concentrations in prefrontal cortex.
|
1 day during the whole experiment
|
|
Δ[Hb]
Time Frame: 1 day during the whole experiment
|
The changes of deoxyhemoglobin concentrations in prefrontal cortex.
|
1 day during the whole experiment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Heart rate
Time Frame: 1 day during the whole experiment
|
Heart rate of patient recorded by bed-side physiological monitor.
|
1 day during the whole experiment
|
|
Blood pressure
Time Frame: 1 day during the whole experiment
|
Blood pressure of patient recorded by bed-side physiological monitor.
|
1 day during the whole experiment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
February 11, 2019
Primary Completion (ANTICIPATED)
August 1, 2019
Study Completion (ANTICIPATED)
December 31, 2019
Study Registration Dates
First Submitted
March 1, 2019
First Submitted That Met QC Criteria
March 5, 2019
First Posted (ACTUAL)
March 6, 2019
Study Record Updates
Last Update Posted (ACTUAL)
March 6, 2019
Last Update Submitted That Met QC Criteria
March 5, 2019
Last Verified
March 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Brain Death of AMS
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Brain Death
-
Centre Hospitalier Régional d'OrléansFisher and Paykel HealthcareNot yet recruiting
-
Société Française d'Anesthésie et de RéanimationRecruiting
-
Liu YonghongEnrolling by invitationSudden Unexpected Death in Epilepsy | Near-Sudden Unexpected Death in EpilepsyChina
-
Hospices Civils de LyonTerminatedSudden Unexpected Death in Epilepsy (SUDEP)France
-
Alexandria UniversityUnknownMaternal Death | Hypoxic Brain InjuryEgypt
-
Hospices Civils de LyonNot yet recruiting
-
Centre Hospitalier Universitaire de NīmesTerminatedStress Disorders, Post-TraumaticFrance
-
Amasya UniversityNot yet recruitingSudden Infant Death Syndrome | Shaken Baby SyndromeTurkey
-
Instituto de Investigación Hospital Universitario...Hospital de Santa Maria, PortugalCompletedPrevention of Kidney Injury Associated With Brain DeathSpain, Portugal
-
Fundació Institut de Recerca de l'Hospital de la...UnknownBiomarkers | Cardiac Sudden Death | Hypoxia Brain | Cell Membrane MicroparticlesSpain
Clinical Trials on Oxygen supply of high-low-high procedure
-
Cancer Institute and Hospital, Chinese Academy...UnknownBrain Death | ComaChina
-
M.D. Anderson Cancer CenterCompleted
-
EgymedicalpediaAin Shams UniversityCompletedBariatric Surgery Candidate | AtelectasisEgypt
-
Johns Hopkins UniversityThrasher Research FundCompleted
-
Yonsei UniversityCompletedObstructive Sleep ApneaKorea, Republic of
-
Tan, LijieUnknown
-
Aga Khan University Hospital, PakistanUnknownApneic Oxygenation
-
Outcomes'10Enrolling by invitation
-
Hôpital de VerdunNot yet recruitingHypercapnic Respiratory Failure | Acute Copd ExacerbationCanada